These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 25823848)
1. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma. Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848 [TBL] [Abstract][Full Text] [Related]
2. High DBC1 (CCAR2) expression in gallbladder carcinoma is associated with favorable clinicopathological factors. Won KY; Cho H; Kim GY; Lim SJ; Bae GE; Lim JU; Sung JY; Park YK; Kim YW; Lee J Int J Clin Exp Pathol; 2015; 8(9):11440-5. PubMed ID: 26617872 [TBL] [Abstract][Full Text] [Related]
3. Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients. Noh SJ; Kang MJ; Kim KM; Bae JS; Park HS; Moon WS; Chung MJ; Lee H; Lee DG; Jang KY Pathology; 2013 Oct; 45(6):574-80. PubMed ID: 24018803 [TBL] [Abstract][Full Text] [Related]
4. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439 [TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma. Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma. Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276 [TBL] [Abstract][Full Text] [Related]
7. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma. Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275 [TBL] [Abstract][Full Text] [Related]
8. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Cha EJ; Noh SJ; Kwon KS; Kim CY; Park BH; Park HS; Lee H; Chung MJ; Kang MJ; Lee DG; Moon WS; Jang KY Clin Cancer Res; 2009 Jul; 15(13):4453-9. PubMed ID: 19509139 [TBL] [Abstract][Full Text] [Related]
9. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
10. B7-H4 expression in ovarian serous carcinoma: a study of 306 cases. Liang L; Jiang Y; Chen JS; Niu N; Piao J; Ning J; Zu Y; Zhang J; Liu J Hum Pathol; 2016 Nov; 57():1-6. PubMed ID: 27349304 [TBL] [Abstract][Full Text] [Related]
11. Expression of Nestin and CD133 in serous ovarian carcinoma. Onisim A; Iancu M; Vlad C; Kubelac P; Fetica B; Fulop A; Achimas-Cadariu A; Achimas-Cadariu P J BUON; 2016; 21(5):1168-1175. PubMed ID: 27837619 [TBL] [Abstract][Full Text] [Related]
12. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma. Ha SY; Kim JH; Yang JW; Bae H; Cho HY; Park CK Pathol Res Pract; 2016 Jul; 212(7):616-21. PubMed ID: 27083241 [TBL] [Abstract][Full Text] [Related]
13. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma. Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of P-glycoprotein and proliferative index in advanced low grade serous ovarian carcinomas. Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL J Chemother; 2003 Aug; 15(4):380-6. PubMed ID: 12962367 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma. Darb-Esfahani S; Kunze CA; Kulbe H; Sehouli J; Wienert S; Lindner J; Budczies J; Bockmayr M; Dietel M; Denkert C; Braicu I; Jöhrens K Oncotarget; 2016 Jan; 7(2):1486-99. PubMed ID: 26625204 [TBL] [Abstract][Full Text] [Related]
16. Aurora-B protein expression is linked to initial response to taxane-based first-line chemotherapy in stage III ovarian carcinoma. Beussel S; Hasenburg A; Bogatyreva L; Hauschke D; Werner M; Lassmann S J Clin Pathol; 2012 Jan; 65(1):29-35. PubMed ID: 22011448 [TBL] [Abstract][Full Text] [Related]
17. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. Lee H; Kim KR; Noh SJ; Park HS; Kwon KS; Park BH; Jung SH; Youn HJ; Lee BK; Chung MJ; Koh DH; Moon WS; Jang KY Hum Pathol; 2011 Feb; 42(2):204-13. PubMed ID: 21056897 [TBL] [Abstract][Full Text] [Related]
18. XB130 expression in human osteosarcoma: a clinical and experimental study. Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762 [TBL] [Abstract][Full Text] [Related]
19. Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response. Martín de la Fuente L; Malander S; Hartman L; Jönsson JM; Ebbesson A; Nilbert M; Måsbäck A; Hedenfalk I Int J Gynecol Pathol; 2018 Mar; 37(2):101-109. PubMed ID: 28481779 [TBL] [Abstract][Full Text] [Related]
20. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis. Kim SH; Kim JH; Yu EJ; Lee KW; Park CK Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]